Mendel Money Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
3,315
-690
-17% -$236K 0.44% 63
2026
Q1
$1.41M Sell
4,005
-125
-3% -$44.6K 0.59% 56
2025
Q4
$1.35M Sell
4,130
-4
-0.1% -$1.27K 0.57% 51
2025
Q3
$1.17M Sell
4,134
-50
-1% -$14.5K 0.49% 58
2025
Q2
$1.17M Sell
4,184
-229
-5% -$64.9K 0.52% 55
2025
Q1
$1.37M Sell
4,413
-104
-2% -$30.7K 0.65% 47
2024
Q4
$1.18M Sell
4,517
-20
-0.4% -$5.93K 0.53% 53
2024
Q3
$1.46M Sell
4,537
-250
-5% -$81.8K 0.63% 45
2024
Q2
$1.5M Buy
4,787
+54
+1% +$15.9K 0.7% 44
2024
Q1
$1.35M Sell
4,733
-69
-1% -$20.2K 0.62% 46
2023
Q4
$1.38M Sell
4,802
-105
-2% -$28.6K 0.66% 45
2023
Q3
$1.32M Buy
4,907
+421
+9% +$105K 0.71% 43
2023
Q2
$996K Buy
4,486
+43
+1% +$9.98K 0.51% 49
2023
Q1
$1.07M Buy
4,443
+242
+6% +$59.4K 0.58% 42
2022
Q4
$1.1M Buy
4,201
+887
+27% +$238K 0.63% 41
2022
Q3
$747K Buy
3,314
+140
+4% +$33.9K 0.47% 48
2022
Q2
$772K Buy
3,174
+84
+3% +$20.6K 0.46% 49
2022
Q1
$747K Buy
+3,090
New +$710K 0.36% 53

Other funds holding AMGN

Mendel Money Management's AMGN Position: Q2 2026 in Review

Mendel Money Management reduced its Amgen (AMGN) stake by 17% in Q2 2026, selling an estimated $236K and leaving 3,315 shares worth $1.2M. The position accounts for 0.44% of the portfolio, ranked #63.

Mendel Money Management first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.5M in Q2 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mendel Money Management held 3,315 shares of Amgen worth $1.2M as of Q2 2026.
  • Mendel Money Management sold 690 Amgen shares in Q2 2026, an estimated $236K.
  • Amgen made up 0.44% of Mendel Money Management's portfolio in Q2 2026, its #63 holding.
  • Mendel Money Management first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
  • Mendel Money Management's Amgen position peaked at $1.5M in Q2 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mendel Money Management's 13F filing for Q2 2026, filed 30 Jul 2026.